These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7041324)

  • 21. Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Rice KL; Kronenberg RS; Hedemark LL; Niewoehner DE
    Br J Dis Chest; 1987 Jul; 81(3):287-92. PubMed ID: 3311120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eaton ML; MacDonald FM; Church TR; Niewoehner DE
    Chest; 1982 Nov; 82(5):538-42. PubMed ID: 7128220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of nebulized salbutamol on lung function and exercise tolerance in patients with severe airflow obstruction.
    Connellan SJ; Gough SE
    Br J Dis Chest; 1982 Apr; 76(2):135-42. PubMed ID: 7093130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are "pink puffers" more breathless than "blue bloaters"?
    Johnson MA; Woodcock AA; Rehahn M; Geddes DM
    Br Med J (Clin Res Ed); 1983 Jan; 286(6360):179-82. PubMed ID: 6401519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases.
    Woodcock AA; Gross ER; Gellert A; Shah S; Johnson M; Geddes DM
    N Engl J Med; 1981 Dec; 305(27):1611-6. PubMed ID: 6796885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.
    Weir DC; Gove RI; Robertson AS; Burge PS
    Thorax; 1990 Feb; 45(2):112-7. PubMed ID: 2180105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of terbutaline on exercise capacity and pulmonary function in patients with chronic obstructive pulmonary disease.
    Iversen ET; Sørensen T; Heckscher T; Jensen JI
    Lung; 1999; 177(4):263-71. PubMed ID: 10384064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise performance following a carbohydrate load in chronic airflow obstruction.
    Brown SE; Wiener S; Brown RA; Marcarelli PA; Light RW
    J Appl Physiol (1985); 1985 Apr; 58(4):1340-6. PubMed ID: 3921518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
    Chiang LL; Yu CT; Kuo HP
    Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of carbohydrate rich versus fat rich loads on gas exchange and walking performance in patients with chronic obstructive lung disease.
    Efthimiou J; Mounsey PJ; Benson DN; Madgwick R; Coles SJ; Benson MK
    Thorax; 1992 Jun; 47(6):451-6. PubMed ID: 1496505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety.
    Singh NP; Despars JA; Stansbury DW; Avalos K; Light RW
    Chest; 1993 Mar; 103(3):800-4. PubMed ID: 8449072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of effective pulmonary blood flow by soluble gas uptake in patients with chronic airflow obstruction.
    Pierce RJ; McDonald CF; Thuys CA; Rochford PD; Barter CE
    Thorax; 1987 Aug; 42(8):604-14. PubMed ID: 3660313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of sympathomimetic amines in the dyspnoea of thyrotoxicosis.
    Tan WC; Cheah JS
    Ann Acad Med Singap; 1983 Jul; 12(3):462-5. PubMed ID: 6678130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperinflation, trapped gas and theophylline in chronic obstructive pulmonary disease.
    Waterhouse JC; Pritchard SM; Howard P
    Monaldi Arch Chest Dis; 1993; 48(2):126-9. PubMed ID: 8518774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of inhaled metaproterenol on exercise performance in patients with stable "fixed" airway obstruction.
    Berger R; Smith D
    Am Rev Respir Dis; 1988 Sep; 138(3):624-9. PubMed ID: 3202416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grading of dyspnoea and walking speed in cardiac disease and in chronic airflow obstruction.
    Warley AR; Finnegan OC; Nicholson EM; Laszlo G
    Br J Dis Chest; 1987 Oct; 81(4):349-55. PubMed ID: 3449121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of mild-to-moderate airflow limitation on exercise capacity.
    Babb TG; Viggiano R; Hurley B; Staats B; Rodarte JR
    J Appl Physiol (1985); 1991 Jan; 70(1):223-30. PubMed ID: 2010380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.